12:00 AM
Nov 14, 2013
 |  BC Innovations  |  Distillery Therapeutics

Indication: Neurology

Indication Target/marker/pathway Summary Licensing status Publication and contact information
Excessive sleepiness Vasopressin 1a (V1a) receptor; V1b receptor Mouse studies suggest antagonizing the V1a or...

Read the full 213 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >